BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$66.92

Market cap

$9.84B

P/E Ratio

36.37

Dividend/share

$0.2

EPS

$1.84

Enterprise value

$10.37B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions ...

Highlights
BRKR's price to earnings (P/E) is 14% lower than its 5-year quarterly average of 42.3
BRKR's gross profit is up by 9% year-on-year and by 2.1% since the previous quarter
Bruker's debt has increased by 40% YoY but it has decreased by 2.6% from the previous quarter
The quick ratio has decreased by 12% from the previous quarter but it has increased by 7% YoY
BRKR's equity is down by 13% YoY and by 3.5% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.bruker.com
Peers: PKI TMO WAT BIO

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
147.08M
Market cap
$9.84B
Enterprise value
$10.37B
Valuations
Price to earnings (P/E)
36.37
Price to book (P/B)
10.58
Price to sales (P/S)
3.95
EV/EBIT
25.21
EV/EBITDA
20.79
EV/Sales
4.14
Earnings
Revenue
$2.51B
EBIT
$411.4M
EBITDA
$498.7M
Free cash flow
$133.2M
Per share
EPS
$1.84
Free cash flow per share
$0.9
Book value per share
$6.33
Revenue per share
$16.95
TBVPS
$18.55
Balance sheet
Total assets
$3.34B
Total liabilities
$2.39B
Debt
$1.15B
Equity
$937M
Working capital
$1.17B
Liquidity
Debt to equity
1.23
Current ratio
2.36
Quick ratio
1.21
Net debt/EBITDA
1.06
Margins
EBITDA margin
19.9%
Gross margin
51.1%
Net margin
11%
Operating margin
17%
Efficiency
Return on assets
7.9%
Return on equity
27.5%
Return on invested capital
17%
Return on capital employed
16.6%
Return on sales
16.4%
Dividend
Dividend yield
0.3%
DPS
$0.2
Payout ratio
10.9%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
-1.12%
1 week
-2.72%
1 month
9.56%
1 year
-17.71%
YTD
-20.25%
QTD
26.12%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$2.51B
Gross profit
$1.28B
Operating income
$427.1M
Net income
$274.9M
Gross margin
51.1%
Net margin
11%
BRKR's gross profit is up by 9% year-on-year and by 2.1% since the previous quarter
BRKR's operating income is up by 7% year-on-year and by 4.4% since the previous quarter
Bruker's revenue has increased by 6% YoY
Bruker's net margin has decreased by 3.5% YoY

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
P/E
36.37
P/B
10.58
P/S
3.95
EV/EBIT
25.21
EV/EBITDA
20.79
EV/Sales
4.14
BRKR's price to earnings (P/E) is 14% lower than its 5-year quarterly average of 42.3
BRKR's EPS is up by 3.4% year-on-year
The stock's price to book (P/B) is 29% more than its 5-year quarterly average of 8.2 and 7% more than its last 4 quarters average of 9.9
BRKR's equity is down by 13% YoY and by 3.5% QoQ
The stock's price to sales (P/S) is 10% more than its 5-year quarterly average of 3.6
Bruker's revenue has increased by 6% YoY

Efficiency

How efficient is Bruker business performance
Bruker's return on invested capital has decreased by 16% YoY
BRKR's return on assets is down by 10% year-on-year
BRKR's return on sales is up by 4.5% since the previous quarter and by 3.8% year-on-year
Bruker's return on equity has increased by 3.8% QoQ

Dividends

What is BRKR's dividend history
Dividend details
DPS
$0.2
Dividend yield
0.3%
Payout ratio
10.9%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 40% greater than its total liabilities
BRKR's total liabilities is up by 17% YoY
The quick ratio has decreased by 12% from the previous quarter but it has increased by 7% YoY
Bruker's debt is 23% more than its equity
BRKR's debt to equity has surged by 60% year-on-year
Bruker's debt has increased by 40% YoY but it has decreased by 2.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.